Task: Answer the MCQ question.
Question: Which drug exhibits a -15.735% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) COc1ccc(NC(=O)/C(=C\c2cccnc2)NC(=O)c2ccc(C)cc2)cc1
b) Cc1ccc(-c2ccc(S(=O)(=O)NCC3CCCO3)cc2)cc1
c) CCOc1ccc(N(Cc2cc3ccc(C)cc3[nH]c2=O)S(=O)(=O)c2ccccc2)cc1
Answer: a. COc1ccc(NC(=O)/C(=C\c2cccnc2)NC(=O)c2ccc(C)cc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)/C(=C\c2cccnc2)NC(=O)c2ccc(C)cc2)cc1
COc1ccc(NC(=O)/C(=C\c2cccnc2)NC(=O)c2ccc(C)cc2)cc1
N-[(E)-3-(4-methoxyanilino)-3-oxo-1-pyridin-3-ylprop-1-en-2-yl]-4-methylbenzamide